According to Centers for Disease Control and Prevention (CDC), human papillomavirus (HPV) refers to a group of more than 100 related viruses that commonly cause infections and do not have any symptoms. Among these, more than 40 types of HPVs cause highly contagious diseases that are transmitted through direct sexual contact, infecting both male and female genitals. The other types of HPV cause nongenital warts that are not sexually transmitted. Though most HPV infections are harmless and heal on their own, certain high-risk types of genital HPV can be persistent and cause cervical, penile, anal, vaginal, and oropharyngeal cancers. Many individuals, especially women, undergo regular HPV tests as a preventive measure. HPV tests help to detect the viral genetic material in a cell sample taken from the cervix.

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

Cervical cancer diagnosis by HPV testing

PART 05: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 06: Market segmentation by product

Global HPV testing market by systems

Global HPV testing market by consumables

PART 07: Market segmentation by end-user

Hospitals

Clinical diagnostic laboratories

Physicians' office laboratories

PART 08: Geographical segmentation

HPV testing market in Americas

HPV testing market in EMEA

HPV testing market in APAC

PART 09: Market drivers

Early detection of cervical cancer to prevent the growing

prevalence

Paradigm shift toward use of HPV home-testing kits

Reimbursements for HPV tests

PART 10: Impact of drivers

PART 11: Market challenges

Pap test: Alternative diagnostic test for cervical cancer

screening

Limited number of health clinics and healthcare settings

in developing countries

Lack of uniformity in screening policies

PART 12: Impact of drivers and challenges

PART 13: Market trends

Expansion of companies in key markets

Co-testing with HPV and Pap tests

Development of mRNA HPV test

PART 14: Vendor landscape

Competitive landscape analysis

PART 15: Key vendor analysis

Abbott Laboratories

BD

Roche Diagnostics

Qiagen

Hologic

Other prominent vendors

PART 16: Appendix

List of abbreviations

PART 17: Explore Technavio